June 15, 2020 10:19 AM EDTUpdated July 30, 08:02 AM

On a hiring spree, Moderna recruits another Amgen vet for the executive committee; Repare, Forma set terms for IPO

John Carroll

Editor & Founder

Amber Tong

→ Moderna CEO Stéphane Bancel didn’t just get its new CFO from Amgen. The biotech — looking to revolutionize vaccine development and beat Covid-19 in lightning …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

On a hiring spree, Moderna recruits another Amgen vet for the executive committee; Repare, Forma set terms for IPO

John Carroll

Editor & Founder

Amber Tong

Sign up to read this article for free.

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Norbert Bischofberger's time as Kronos CEO ends as biotech seeks new life

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

Novartis to cut 139 jobs in NJ as part of commercial refocus

Recursion reduces workforce; Oxford Nanopore teams up with UK Biobank

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

On a hir­ing spree, Mod­er­na re­cruits an­oth­er Am­gen vet for the ex­ec­u­tive com­mit­tee; Re­pare, For­ma set terms for IPO

Editor & Founder

Sign up to read this article for free.

more like this

On a hiring spree, Moderna recruits another Amgen vet for the executive committee; Repare, Forma set terms for IPO